(Q81294620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

allergic contact dermatitis

7 January 2020

main subject

1 reference

Didier M Lambert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1701-1702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Endocannabinoids and the regulation of their levels in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Biochemistry and pharmacology of endovanilloids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Cannabinoids and PPARalpha signalling.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

A second fatty acid amide hydrolase with variable distribution among placental mammals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Attenuation of allergic contact dermatitis through the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Cannabinoid receptors as novel targets for the treatment of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700168

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17868162%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference